Authors
Ashok Chandra Rao R, Associate Professor1
Dinesh Prabhu D, Assistant Professor1 & Consultant Diabetologist2
1Department of Medicine, SUT Academy of Medical Sciences, Vencode, Trivandrum
2Consultant Diabetologist
Abstract
Hypoglycaemia is a dangerous complication that could occur while treating diabetes. Inpatients with type 2 diabetes, avoidance of hypoglycaemia is desirable in all; and absolutely necessary in many. Currently, clinicians have access to a variety of medications that achieve the dual objective of reaching targets and avoiding hypoglycaemia.
This brief review aims to highlight the dangers of hypoglycaemia and to familiarize clinicians with non-insulin based medications that avoid hypoglycaemia while treating patients with type 2 diabetes mellitus.
Keywords: Hypoglycaemia, Type 2 diabetes, Pioglitazone, GLP-1 mimetics, DPP4 inhibitors, SGLT2 inhibitors